YOLFTbeta
M1 Kliniken AG

M1 Kliniken AG

M12 · XETRA · Healthcare / Medical Distribution

19.20EUR-0.56 (-2.83%)

Price History

Full chart

Market Stats

Previous Close19.76
Open19.76
Day Range19.20 – 20.00
52-Week Range12.73 – 21.70
Volume2.70K
Market Cap385.95M
P/E (TTM)19.26
Forward P/E0.00
EPS1.08
Dividend Yield5.77%
Beta1.09
50-Day Avg19.40
200-Day Avg17.71

About

M1 Kliniken AG, together with its subsidiaries, provides aesthetic medicine and plastic surgery services in Germany, Austria, the Netherlands, Switzerland, Croatia, Hungary, Bulgaria, and Romania. It operates through Beauty and Trade segments. The Beauty segment provides aesthetic surgery services, such as breast augmentation, eyelid lifts, and liposuction; and other aesthetic medical treatment services, including injections with hyaluronic acid and botulinum toxin. This segment also manages a private clinic for plastic and aesthetic surgery; and medical specialist centers for aesthetic and plastic medicine under the Schlossklinik and M1 Med Beauty names. The Trade segment sells pharmaceuticals and medical products for various therapeutic areas of oncology, HIV/AIDS, neurology, rheumatology, other chronic diseases, and aesthetic medicine. The company was incorporated in 2007 and is based in Berlin, Germany. M1 Kliniken AG is a subsidiary of MPH Health Care AG.

Company Details

  • SectorHealthcare
  • IndustryMedical Distribution
  • CEOMr. Attila Strauss
  • Employees280
  • HeadquartersGrünauer Straße 5, Berlin, Germany, 12557, Germany
  • Websitehttps://www.m1-kliniken.de

Leadership

  • Mr. Attila StraussMember of Management Board & CEO
  • Ms. Katharina ZimmnauCFO & Member of Executive Board

Financials

Income Statement

Currency: EUR2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue6.08M23.02M34.93M35.95M47.19M65.21M77.22M159.59M314.61M285.29M316.32M339.18M364.30M
Growth (%)-+278.51%+51.74%+2.95%+31.26%+38.17%+18.42%+106.68%+97.14%-9.32%+10.88%+7.23%+7.40%
Cost of Revenue6.30M19.74M26.38M31.74M36.04M51.70M63.71M145.98M288.55M263.57M283.85M275.58M316.87M
Gross Profit-218.00K3.28M8.55M4.21M11.15M13.51M13.50M13.61M26.06M21.72M32.47M63.60M47.43M
Gross Margin-3.58%14.24%24.47%11.72%23.63%20.72%17.49%8.53%8.28%7.61%10.27%18.75%13.02%
Operating Expense465.00K1.81M1.98M-146.00K5.60M7.11M5.69M9.20M13.92M12.38M16.77M36.85M10.69M
Operating Income-683.00K1.47M6.57M4.36M5.55M6.39M7.81M4.41M12.13M9.35M15.70M26.75M36.74M
Operating Margin-11.23%6.36%18.81%12.12%11.75%9.81%10.12%2.76%3.86%3.28%4.96%7.89%10.09%
EBITDA-642.00K1.58M7.26M5.79M7.82M8.81M11.21M10.59M19.78M16.07M21.79M33.44M40.49M
EBITDA Margin-10.56%6.85%20.78%16.09%16.57%13.52%14.52%6.63%6.29%5.63%6.89%9.86%11.11%
Net Income109.00K4.58M6.63M5.01M5.78M6.61M9.73M6.82M8.91M4.32M10.27M16.02M22.13M
Net Income Margin1.79%19.92%18.98%13.93%12.24%10.14%12.60%4.28%2.83%1.51%3.25%4.72%6.08%
Interest Expense0202.00K270.00K14.00K7.76K8.24K342.34K721.61K916.50K827.94K1.35M1.93M1.54M
Interest Expense % of Total Revenue0.00%0.88%0.77%0.04%0.02%0.01%0.44%0.45%0.29%0.29%0.43%0.57%0.42%

Balance Sheet

Currency: EUR2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets22.38M38.70M33.19M32.19M50.57M69.55M92.81M188.74M198.11M197.02M212.95M187.87M189.29M
Total Liabilities7.26M13.31M3.44M1.93M3.29M5.81M24.59M73.42M58.21M53.97M69.73M53.65M39.28M
Total Equity15.12M25.39M29.75M30.26M47.28M63.74M68.22M85.75M95.03M95.52M113.25M106.10M119.93M
Cash609.00K2.40M412.45K5.81M14.69M25.38M9.10M21.96M37.87M35.15M22.38M21.43M37.76M
Total Debt4.27M2.02M177.01K30.65K1.17M665.23K11.40M39.32M30.93M19.67M17.04M10.42M10.26M
Net Debt3.66M-377.00K-235.44K-5.78M-14.47M-25.23M2.30M17.36M-6.93M-15.48M-5.34M-11.02M-27.51M

Cash Flow

Currency: EUR2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-5.21M912.58K-171.80K7.94M2.09M2.86M-5.37M9.54M15.68M20.77M7.81M30.55M33.80M
Investing Cash Flow1.18M-7.00M200.40K1.98M-4.65M-1.94M-3.34M3.12M213.19K-1.12M-9.36M-5.67M-645.81K
Financing Cash Flow-7.71M-2.01M-4.51M11.44M9.78M-7.58M377.65K4.03M-22.37M-14.81M-30.44M-13.41M
Capital Expenditure502.00K146.66K677.56K842.00K3.29M2.10M1.35M1.45M1.34M1.77M1.01M995.38K110.22K
Free Cash Flow-5.72M765.91K-849.35K7.09M-1.20M764.51K-6.72M8.09M14.35M19.00M6.80M29.55M37.84M
Dividends Paid-4.50M4.50M4.50M4.50M4.95M5.25M128.51K1.66M1.82M1.98M9.31M9.31M
FCF to OCF109.63%83.93%494.40%89.39%-57.71%26.72%125.06%84.84%91.49%91.47%87.07%96.74%111.95%
Dividend Paid to FCF-587.54%-529.82%63.43%-373.84%647.47%-78.18%1.59%11.55%9.60%29.13%31.50%24.60%

Earnings

Report DateJun 20, 2016Aug 4, 2016Feb 3, 2017Oct 5, 2017May 30, 2018Aug 27, 2018Aug 27, 2019May 20, 2020Aug 26, 2020May 27, 2021Sep 1, 2021Dec 1, 2021Mar 2, 2022May 23, 2022Aug 17, 2022Nov 14, 2022Apr 20, 2023Aug 31, 2023Nov 16, 2023Apr 18, 2024Sep 10, 2024Nov 19, 2024Jun 5, 2025Sep 8, 2025Nov 19, 2025
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00-0.000.00
EPS Actual0.470.190.140.250.130.200.230.330.120.240.170.000.280.000.070.000.000.000.000.000.530.000.310.630.00
Surprise-------------------------
Timing----------------Pre-marketPre-marketPre-market---Pre-market--

Key Statistics & Ratios

Market Cap385.95M
Enterprise Value284.47M
Trailing P/E19.26
Forward P/E0.00
PEG Ratio0.00
Price / Sales1.50
Price / Book2.95
EPS1.08
Book Value6.69
Revenue (TTM)257.36M
Gross Profit (TTM)51.70M
EBITDA32.57M
Profit Margin7.86%
Operating Margin20.43%
Return on Equity15.30%
Return on Assets10.46%
Shares Outstanding18.56M
Shares Float18.56M
Beta1.09
Dividend Yield5.77%
Dividend Rate1.20
Payout Ratio46.30%

Dividends

20261×
1.20Jul 9, 2026
20251×
0.50Jul 17, 2025
20241×
0.50Jul 18, 2024
20191×
0.30Aug 26, 2019
20181×
0.30Jul 11, 2018
20171×
0.30Jun 28, 2017
20161×
0.30Jun 16, 2016